Medtronic (MDT): financials, SEC filings and peers
Medtronic (MDT) is a health care equipment company in the Health Care sector of the S&P 500, headquartered in Galway, Ireland.
It was founded in 1949 and joined the S&P 500 on October 31, 1986.
Its fiscal year ends in April, and its shares trade on the NYSE.
In its SEC filings it is classified as “Electromedical & Electrotherapeutic Apparatus”.
Medtronic at a glance
- Revenue (12 months)
- $37.5B
- Revenue growth
- +9.8%
- Operating margin
- 18.1%
- Net income (12 months)
- $5.2B
- Free cash flow (12 months)
- $6.1B
- Cash
- $1.7B
- Debt
- $28.2B
- Diluted EPS (12 months)
- $4.07
Twelve months to July 31, 2026, from the 10-Q filed September 3, 2026.
Latest twelve months
Over the twelve months to July 31, 2026, Medtronic reported revenue of $37.5 billion, up 9.8% from a year earlier.
Its operating margin was 18.1%: for every $100 of sales, about $18 was left as operating profit.
Net income was $5.2 billion (13.9% of revenue), 12.3% higher than a year earlier.
Operating cash flow was $8.0 billion and capital spending $1.9 billion, leaving free cash flow of $6.1 billion (16.3% of revenue).
At the end of the period it held $1.7 billion in cash and $28.2 billion in debt, a net debt position of $26.5 billion.
Five-year trend
- Revenue went from $30.1 billion in fiscal 2021 to $36.4 billion in fiscal 2026, about 3.8% a year.
- Revenue has grown for 3 fiscal years in a row.
- Operating margin widened from 14.9% to 17.8% over the same years.
- Free cash flow was positive in each of the last 6 fiscal years.
| Fiscal year | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $31.7B | $31.2B | $32.4B | $33.5B | $36.4B |
| Revenue growth | 5.2% | -1.4% | 3.6% | 3.6% | 8.4% |
| Operating margin | 18.2% | 17.6% | 15.9% | 17.8% | 17.8% |
| Net income | $5.0B | $3.8B | $3.7B | $4.7B | $4.8B |
| Free cash flow | $6.0B | $4.6B | $5.2B | $5.2B | $5.4B |
| Diluted EPS | $3.73 | $2.82 | $2.76 | $3.61 | $3.73 |
Fiscal years as reported in Medtronic’s 10-K filings. Free cash flow is operating cash flow minus capital spending.
Recent SEC filings
Companies like Medtronic
Other S&P 500 companies in Health Care Equipment:
- ABTAbbott LaboratoriesNorth Chicago, Illinois
- BAXBaxter InternationalDeerfield, Illinois
- BDXBecton DickinsonFranklin Lakes, New Jersey
- BSXBoston ScientificMarlborough, Massachusetts
- DXCMDexcomSan Diego, California
- EWEdwards LifesciencesIrvine, California
- GEHCGE HealthCareChicago, Illinois
- IDXXIdexx LaboratoriesWestbrook, Maine
More from Health Care
Questions about Medtronic
Is Medtronic's revenue growing?
Yes. Revenue for the twelve months to July 31, 2026 was $37.5 billion, up 9.8% from a year earlier, according to its SEC filings.
Is Medtronic profitable?
Yes. It earned $5.2 billion in net income over the twelve months to July 31, 2026, a net margin of 13.9%.
Does Medtronic have more cash or more debt?
At July 31, 2026 it had $1.7 billion in cash and $28.2 billion in debt, so more debt than cash.
When did Medtronic last file financial results?
Its latest quarterly report (10-Q) was filed with the SEC on September 3, 2026.
Which companies are similar to Medtronic?
In the S&P 500, Medtronic is grouped in Health Care Equipment within the Health Care sector. Abbott Laboratories (ABT), Baxter International (BAX), Becton Dickinson (BDX), Boston Scientific (BSX), Dexcom (DXCM) are in the same group.
Understand the numbers
Source: Medtronic’s filings with the U.S. Securities and Exchange Commission (EDGAR), retrieved September 27, 2026. Figures are as reported by the company and may be restated. This page is for information only and is not financial advice.